Farmed Shrimp Disease and Welfare Crisis

Devastating disease outbreaks including Early Mortality Syndrome and White Spot Disease cause mass mortality in farmed shrimp, raising welfare questions about the suffering involved in disease events.

Key Facts

Early Mortality Syndrome (EMS) caused losses exceeding USD 1 billion in Southeast Asian shrimp production during 2012-2014
EMS causes hepatopancreatic damage resulting in mass mortality within 30 days of pond stocking
White Spot Syndrome Virus (WSSV) has caused losses exceeding USD 6 billion globally since its emergence in the 1990s
Disease outbreaks in intensive shrimp ponds can kill 80-100% of animals in days to weeks
Biosecurity improvements and reduced stocking density lower disease incidence but are not universally adopted

Welfare Considerations

Mass mortality disease events in shrimp farming involve enormous numbers of individuals — billions across affected ponds — dying from organ damage, viral hemorrhage, or bacterial infection over days to weeks. The welfare significance depends on contested questions about crustacean sentience, but the scale of individuals affected makes precautionary welfare consideration appropriate. Disease-driven suffering in farmed shrimp is preventable through better biosecurity, lower stocking densities, and water quality management. Consumer demand for certified, disease-managed shrimp production provides market signals for investment in prevention over treatment.

What You Can Do

Choose shrimp products certified under standards that include disease management and biosecurity criteria
Support research into crustacean sentience and welfare to inform appropriate standards for shrimp farming
Advocate for lower stocking density standards in international shrimp aquaculture certification
Reduce shrimp consumption to lower demand on intensive systems where disease events are common and severe